Go to content
UR Home

Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality

URN to cite this document:
DOI to cite this document:
Hähnel, Viola ; Peterhoff, David ; Bäuerlein, Veronika ; Brosig, Andreas-Michael ; Palmer, Irene ; Johnson, Christian ; Bica, Adelina ; Totir, Monica ; Ossner, Thomas ; Stemmer, Barbara ; Toelge, Martina ; Schütz, Anja ; Niller, Hans-Helmut ; Schmidt, Barbara ; Wagner, Ralf ; Gessner, Andre ; Burkhardt, Ralph ; Offner, Robert
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 15 Mar 2021 11:31


The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 patients. Convalescent plasma donors were screened as follows: 1) previously confirmed SARS-CoV-2 ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons